Kontakt
A-Z
Träger / Förderer
Datenschutz
Impressum
Hilfe
Mein Konto
English
Katalog
Einfache Suche
Erweiterte Suche
Browsen (DDC)
Suchverlauf
Meine Auswahl
Hilfe
Datenshop
Mein Konto
Ablieferung von Netzpublikationen
Informationsvermittlung
Über die Deutsche
Nationalbibliothek
Katalog der Deutschen Nationalbibliothek
Gesamter Bestand
Musikarchiv
Exilsammlungen
Buchmuseum
Suchformular zurücksetzen
Expertensuche
?
Servicezeiten in Frankfurt am Main ab 1. Dezember 2025: Montag bis Freitag 9–18 Uhr und Samstag 10–16 Uhr
Service hours in Frankfurt am Main from 1 December 2025: Monday to Friday 9:00-18:00 and Saturday 10:00-16:00
Dienstag 9. Dezember 2025: Die Lesesäle der Deutschen Nationalbibliothek in Leipzig öffnen wegen einer Personalversammlung erst ab 13 Uhr. // Tuesday 9 December 2025: The reading rooms of the German National Library in Leipzig will open at 13:00 due to a staff assembly.
Ergebnis der Suche nach:
"Originator"
im Bestand: Gesamter Bestand
11 - 20 von 68
Datum (neuestes zuerst)
Datum (ältestes zuerst)
Titel (A-Z)
Titel (Z-A)
Name (A-Z)
Name (Z-A)
Interne ID-Nr. aufsteigend
Interne ID-Nr. absteigend
11
Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab
Fischer, Sarah Cornelia. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2021
12
Patients Retransitioning from Biosimilar TNFα Inhibitor to the Corresponding Originator After Initial Transitioning to the Biosimilar: A Systematic Review
Enthalten in BioDrugs 6.12.2021: 1-13
13
The Economic Impact of Originator-to-Biosimilar Non-medical Switching in the Real-World Setting: A Systematic Literature Review
Enthalten in Advances in therapy 15.11.2021: 1-33
14
Effect of Originator Infliximab Treatment on Disease-Related Hospitalizations, Work Productivity and Activity Impairment, and Health Resource Utilization in Patients with Crohn’s Disease in a Real-Life Setting: Results of a Prospective Multicenter Study in Germany
Enthalten in Inflammatory intestinal diseases Bd. 6, 2021, Nr. 1: 48-60
15
How Similar Is Biosimilar? A Comparison of Infliximab Therapeutics in Regard to Charge Variant Profile and Antigen Binding Affinity
Enthalten in Biotechnology journal Bd. 14, 2019, Nr. 4. 9 S.
16
Different Policy Measures and Practices between Swedish Counties Influence Market Dynamics: Part 1—Biosimilar and Originator Infliximab in the Hospital Setting
Enthalten in BioDrugs 3.4.2019: 1-13
17
Different Policy Measures and Practices between Swedish Counties Influence Market Dynamics: Part 2—Biosimilar and Originator Etanercept in the Outpatient Setting
Enthalten in BioDrugs 3.4.2019: 1-8
18
Bettymania and the Death of Celebrity Culture
Enthalten in Historical social research / Supplement 2019, Nr. 32: 139-164
19
Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study
Enthalten in BioDrugs 20.10.2018: 1-11
20
Impact of an alternative steroid on the relative bioavailability and bioequivalence of a novel versus the originator formulation of abiraterone acetate
Enthalten in Cancer chemotherapy and pharmacology 10.7.2017: 1-8
11 - 20 von 68
Alle Materialarten
>
Artikel (68)
Alle Standorte
>
Online (frei zugänglich) (68)
Aktionen
In meine Auswahl übernehmen
Druckansicht
Versenden
News-Feed
Administration